Recent research has highlighted the epidemiology of CKD, particularly its prevalence in vulnerable populations, such as agricultural workers and children in endemic regions. Factors contributing ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The study population consisted of 1301 patients. A total of 338 patients (26%) with HF were found to have CKD. Demographic and clinical characteristics according to the presence or absence of CKD ...

Aims The epidemiology of the five stages of chronic kidney disease (CKD) in systolic heart failure (HF) patients has predominantly been described in hospitalized White patients, with little known ...

【导读】慢性肾病是糖尿病最常见的并发症，但迄今为止，有关慢性肾病在中国成年糖尿病患者中分布情况的全面数据尚属空白。此外，在了解中国成年糖尿病患者中慢性肾脏病与心血管健康（CVH）之间的关系方面也存在研究空白。2025年1月11日，上海交通大学医学院附属第六人民医院内分泌代谢科侯旭宏教授和中国疾病预防控制中心慢 ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Taking charge of your health is one of the most powerful choices you can make, and prioritising your kidneys plays a vital ...

In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...

Not having a formal CKD diagnosis significantly increases ... where the field of epidemiology sparked my fascination. I was eager to explore its real-world implications rather than focusing ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...